Biology of aging
Senescence, epigenetics, cellular repair, and the mechanisms scientists are trying to change.
A clearer view of longevity science
We’re building an independent guide to the science, companies, clinical trials, and ideas shaping how humans age—written for curious people, not just researchers.
No miracle cures. No breathless headlines.
Evidence signal
Our editorial lensEvery major claim will be labeled by the strength and maturity of the evidence behind it.
Coming to MoreYears.news
Senescence, epigenetics, cellular repair, and the mechanisms scientists are trying to change.
Drugs, gene therapies, diagnostics, nutrition, and lifestyle—sorted by actual evidence.
New papers and clinical trials translated into what happened, what didn’t, and what comes next.
The researchers, startups, funders, and institutions moving longevity science forward.
The MoreYears story method
Longevity headlines often race ahead of the research. Our articles will make the gap visible, so readers can quickly understand what changed and how much confidence it deserves.
Explore all research guidesThe finding in plain English—without turning a possibility into a promise.
Cell, animal, observational, clinical, or replicated human research—clearly labeled.
Study limits, conflicts, missing data, and the distance between a result and a treatment.
The next experiment, trial milestone, regulatory decision, or result that could change the picture.
Now available to explore
Our first editorial-format demonstration makes content status, evidence maturity, reporting confidence, caveats, provenance, and update history visible—without presenting a real medical claim.
Demonstration · not current reporting
Explore the complete article structure, then visit Latest for an honest view of what is—and is not—published yet.
Open the format previewOur promise
“We’ll be optimistic about what science can do—and honest about what it hasn’t proven yet.”
MoreYears.news is under active development. This first page is a live technical launch; full editorial coverage is coming next.